Clinical Scorecard: Mapping Molecular Discordance in the Brain

At a Glance

Key Highlights

• Single-cell proteomics reveals discordance between gene expression and protein abundance.
• Direct measurement of protein levels without antibody reliance enhances cellular identity understanding.
• Key developmental transitions linked to neurodevelopmental vulnerability identified.
• High-risk genes show high transcript levels but low protein abundance, indicating regulatory buffering.
• Potential for insights into neurodevelopmental disorders through protein regulation analysis.

Guideline-Based Recommendations

Diagnosis

• Utilize single-cell proteomics to assess protein expression in neurodevelopmental contexts.

Management

• Integrate proteomic data with genetic and functional analyses for comprehensive understanding.

Monitoring & Follow-up

• Track protein expression changes across developmental stages to identify risk factors.

Risks

• Consider the implications of post-transcriptional regulation in neurodevelopmental disorders.

Patient & Prescribing Data

Individuals at risk for neurodevelopmental disorders, particularly during prenatal development.

Understanding protein regulation may inform therapeutic strategies for neurodevelopmental conditions.

Clinical Best Practices

• Apply single-cell proteomics to various developmental stages for broader insights.
• Combine proteomic findings with genetic data to elucidate mechanisms of neurodevelopmental disorders.

References

• UC San Francisco Study
• Stanford University Research